{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase I\/II, Open-Label, Multicenter Study of ALE.P02 (Claudin-1 Targeted Antibody-Drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+\nSquamous Solid Tumors","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-i-ii-open-label-multicenter-study-of-ale-p02-claudin-1-targeted-antibody-drug-conjugate-as-a-monotherapy-in-adult-patients-with-selected-advanced-or-metastatic-cldn1squamous-solid-tumors\/#breadcrumbitem"}]}